BGR GOVERNMENT AFFAIRS

Lobbying for BIOMARIN PHARMACEUTICAL INC. · Biotechnology company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $50,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Health Issues

Provide strategic counsel and advocacy on issues relating to biopharmaceuticals for rare diseases driven by genetic causes generally, or BioMarin Pharmaceutical specifically.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.